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Screening for Generalized Anxiety Disorder in inpatient
psychosomatic rehabilitation: pathological worry and the
impact of depressive symptoms
Screening nach der Generalisierten Angststörung in einer Fachklinik für
Psychotherapie und Psychosomatik: pathologisches Sich-Sorgen und
der Einfluss von Depressivität
Abstract
Objective: Pathological worry is considered to be a defining feature for
GeneralizedAnxietyDisorder(GAD).ThePennStateWorryQuestionnaire
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(PSWQ) is an instrument for assessing pathological worry. Two earlier
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studies demonstrated the suitability of the PSWQ as screening instru-
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2 ment for GAD in outpatient and non-clinical samples. This study exam-
ined the suitability of the PSWQ as a screening instrument for GAD in Eric Leibing
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a German inpatient sample (N=237). Furthermore, a comparison of
patients with GAD and patients with depression and other anxiety dis-
orders regarding pathological worry and depression was carried out in
a sub-sample of N=118 patients.
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Method: Cut-off scores optimizing sensitivity, optimizing specificity and
simultaneouslyoptimizingbothsensitivityandspecificitywerecalculated
for the PSWQ score by receiver operating characteristic analysis (ROC). 2 Paracelsus-Roswitha-Klinik,
Bad Gandersheim, Germany Differences regarding pathological worry and depression measured by
thePSWQandtheBeckDepressionInventory(BDI)acrossfivediagnostic
subgroupswereexaminedbyconductingone-wayANOVAs.Theinfluence
of depression on pathological worry was controlled by conducting an
ANCOVA with BDI score as a covariate.
Results: The ROC analysis showed an area under the curve of AUC=.67
(p=0.02) with only 54.4% of the patients correctly classified.
Comparison of diagnostic subgroups showed that after controlling the
influence of depression, differences referring to pathological worry
between diagnostic subgroups no longer existed.
Conclusions:Contrarytotheearlierresultswefoundthattheuseofthe
PSWQasascreeninginstrumentforGADatleastinasampleofpsycho-
therapy inpatients is not meaningful. Instead of that, the PSWQ can be
used to discriminate high from low worriers in clinical samples. Thus,
the instrument can be useful in establishing e.g. symptom-oriented
group interventions as they are established in behavioural-medicine
inpatient settings. Furthermore, our findings stress the influence of
(comorbid) depressive symptoms on the process of worrying.
Keywords: worry, Generalized Anxiety Disorder, Penn State Worry
Questionnaire, depression, inpatients
Zusammenfassung
Zielsetzung:PathologischesSich-SorgengiltalseinesderKernmerkmale
der Generalisierten Angststörung (GAS). Der Penn State Worry Ques-
tionnaire (PSWQ) erfasst pathologisches Sich-Sorgen. In zwei früheren
StudienwurdedieEignungdesPSWQalsScreening-InstrumentfürGAS
bei ambulanten Patienten und in nicht-klinischen Stichproben nachge-
wiesen. Die vorliegende Studie untersuchte die Eignung des PSWQ als
Screening-InstrumentfürGASbeistationärenPatienteneinerKlinikfür
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Patienten mit GAD sowie Patienten mit Depression und anderen
Angststörungen hinsichtlich des pathologischen Sich-Sorgens und der
depressivenSymptomatikineinerSubstichprobevonN=118Patienten
miteinander verglichen.
Methodik: Anhand einer Receiver Operating Characteristic Analysis
(ROC) wurden Cut-off-Werte für den PSWQ bestimmt, zum einen mit
einer Betonung der Sensitivitität, zum anderen der Spezifizität sowie
einer Ausbalancierung beider. Unterschiede im pathologischen Sich-
Sorgen und der depressiven Symptomatik, erfasst mit dem PSWQ und
dem Beck Depressionsinventar (BDI) über fünf diagnostische Subgrup-
pen, wurden anhand einfaktorieller Varianzanalysen untersucht. Der
Einfluss der depressiven Symptomatik wurde anhand einer Kovarianz-
analyse mit dem BDI als Kovariate untersucht.
Ergebnisse: Die ROC Analyse ergab ein 'area under the curve' von
AUC=,67 (p=0,02) mit nur 54,4% richtig klassifizierten Patienten.
Ein Vergleich der diagnostischen Subgruppen im Hinblick auf das Sich-
Sorgen zeigte, dass diese keine Unterschiede mehr aufwiesen, wenn
der Einfluss der depressiven Symptomatik kontrolliert wurde.
Fazit: Entgegen früheren Befunden scheint der PSWQ als Screening-
Instrument für GAS zumindest in der untersuchten Stichprobe von sta-
tionären Patienten nicht geeignet zu sein. Der PSWQ kann jedoch dazu
verwendet werden, Patienten mit ausgeprägtem Sich-Sorgen zu identi-
fizieren und so die Zuweisung z. B. zu indikativen Gruppen in der statio-
nären verhaltensmedizinischen Versorgung zu erleichtern. Darüber
hinaus betonen die Ergebnisse den Einfluss von (komorbider) Depres-
sivität auf den Prozess des Sich-Sorgens.
Introduction
Generalizedanxietydisorder(GAD)isacommondisorder
with high 12-month prevalence of 3.1% [1]. The disorder
is associated with severe psychosocial impairment, is
typically chronic in course and often associated with co-
morbid mental disorders such as depressive disorders
andotheranxietydisorders[2],[3],[4].GADischaracter-
ised by chronic, excessive and uncontrollable worrying
referring to different areas of everyday life [5], [6]. In
addition, patients with GAD suffer from complaints such
as irritability, restlessness, muscle tension, difficulty
concentrating, sleep difficulties, feeling keyed up and
easy fatigability [7]. Pathological worry is considered to
be a defining feature for GAD [8]. These worries are ex-
perienced as uncontrollable and patients spend consid-
erable time worrying [9]. Obviously, patients suffering
fromanxietydisordersingeneralareconcernedbyseveral
worries. Nevertheless, Chelminski and Zimmerman [10]
found significantly higher levels of pathological worry for
patients with GAD in comparison to other anxiety dis-
orders.
Intwoearlierstudies,thePennStateWorryQuestionnaire
(PSWQ)[11]wasusedasascreeninginstrumentforGAD
[12], [13]. The PSWQ was developed to measure the
specific trait of worry in both clinical and non-clinical
populations. It is a commonly used and psychometrically
sound measure [14]. Individuals diagnosed with GAD
scoresignificantlyhigheronthePSWQthandothosewho
meet only some of the GAD criteria [11] as well as indi-
viduals meeting the criteria for other anxiety disorders
[15].
Behar et al. [12] and Fresco et al. [13] examined the
screening suitability of the PSWQ in different samples by
the use of receiver operating characteristic analyses
(ROC). A ROC analysis enables to evaluate the ability of
a test to discriminate individuals with a characteristic
(e.g., GAD) from individuals without that characteristic.
Behar et al. [12] compared PSWQ scores from 159
treatment-seeking GAD patients with PSWQ scores of
113 nonanxious controls. A PSWQ cut-off-score of 45
provided the best balance of sensitivity (0.99) and spe-
cificity (0.98). In a second study, Behar et al. [12] exam-
ined a large sample of unselected college students
(N=2449). In this sample, a PSWQ cut-off-score of 62
provided the best balance of sensitivity (0.86) and spe-
cificity(0.75).Onelimitationofthisstudywastheassess-
mentofGADbyself-reportmeasures.Further,thesample
did not consist of participants seeking treatment.
Fresco et al. [13] examined the ability of the PSWQ to
correctly identify patients with GAD in a sample of outpa-
tients seeking treatment at an anxiety disorders clinic.
Theauthorsinvestigatedthreediagnosticgroups:patients
with GAD (n=28), patients with Social Phobia (n=114)
and patients with a primary diagnosis of Social Phobia
and a secondary diagnosis of GAD (n=22). By discrimin-
ating 50 patients with either primary or secondary GAD
from 114 patients with Social Phobia, the analysis re-
vealedastrongROCcurveforthePSWQtotalscore(Area
Under Curve [AUC]=0.74) that was significantly better
than chance in classifying individuals with GAD versus
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optimized(cut-offscore=65),63.4%ofthepatientswere
correctly classified. Because of a high degree of overlap
betweenthetwoanxietydisorders,theauthorstaketheir
results as a strong support for the use of the PSWQ as
initialscreeninginstrumentforGAD.Nevertheless,Fresco
et al. [13] point out that the generalization of theses
findings are strongly limited due to the influence of the
modalitiesofastudy(e.g.,sample,diagnosticprocedure,
context of exploration).
As the two earlier studies [12], [13] referred to college
students and outpatient samples, our research question
waswhetherthePSWQcanbeusedasascreeninginstru-
mentforGADinaGermaninpatientsample.(Asaspecial
feature of the health care system in Germany, not only
patients with severe psychiatric disorders, but also pa-
tients with less severe disorders such as anxiety dis-
orders,depressionandsomatoformdisordersaretreated
ininpatienthealthcare.)Asthediscrepancybetweenthe
high frequency of GAD, and the duration and validity of
its diagnosis [16] shows, the detection rates regarding
thisdisorderarenotyetsufficient.Thisinsufficiencycould
be associated with the overlap of symptoms between
GADanddepressivedisordersaswellaswithsomatoform
disorders, which are both quite frequently represented
in German inpatient samples. Therefore, in this context
the suitability of the PSWQ as a screening instrument for
GAD would be a great convenience in order to not over-
look this (comorbid) disorder in clinical daily routine.
Nevertheless, as the specificity of pathological worry in
GAD was questioned by several authors [17], [18], an-
other goal was to examine the specificity of pathological
worry for GAD by comparing the levels of pathological
worryamongpsychotherapyinpatientswithGAD,several
other anxiety disorders and depression. In some studies,
significantassociationsbetweenPSWQscoresandrumin-
ationcouldbefound[19].Thus,anassociationofdepres-
sive symptoms with the process of worrying can be ex-
pected.
Method
Participants and diagnoses
This study refers to an unselected sample of N=293
psychotherapy inpatients who were treated in a German
psychosomaticrehabilitationclinic(Paracelsus-Roswitha-
Klinik, Bad Gandersheim, Germany). The study was ap-
provedbytheBundesversicherungsanstaltfürAngestellte
(BfA). Data were collected in the context of routine evalu-
ation.Diagnosticclassificationwasconductedbyroutine
structured clinical interviews (Mini-DIPS) [20] according
to DSM-IV [5] and ICD-10 [6] by trained psychotherapists
under regular supervision. The primary diagnosis was
definedasthediagnosisassociatedwiththemostsevere
impairment. Patients with substance abuse, psychotic or
bipolardisorders,eatingdisorders,obsessive-compulsive
disorders, and severe personality disorders (Cluster A
and Cluster B) were excluded. Finally, N=237 patients
wereincludedinthepresentinvestigation.Themeanage
of the sample was 48.40 years (SD=9.06), 144 (60.8%)
patients were female, and 140 (59.07%) were married.
Regarding the primary diagnosis, N=18 (7.6%) patients
of the sample fulfilled the criteria for GAD. N=32 (13.5%)
patients had a primary or secondary GAD diagnosis. The
frequencyofallprimarydiagnosesisdisplayedinTable1.
Assessment
The Penn State Worry Questionnaire (PSWQ) [11] is a
self-report measure to assess pathological worry in GAD
patients. Satisfactory reliability and validity could be
demonstrated for the German version of the PSWQ [21],
[22].Byaddingupthevalue(five-pointscale,range1–5)
of all 16 items (e.g., “I’m always worrying about some-
thing“) a score from 16 to 80 can be reached.
The Beck Depression Inventory (BDI) [23], [24] is a 21-
item self-report measure which assesses the severity of
depressivesymptomsona4-pointscale.Thewidelyused
instrument shows satisfactory reliability with an internal
consistency of .88.
Procedure and statistical methods
Inordertotestwhetherpatientswithprimaryorcomorbid
GAD score significantly higher in the PSWQ than do Non-
GAD patients, a one-tailed t-test was conducted and an
effect size according to Cohen [25] was calculated.
TheutilityofthePSWQasascreeninginstrumentforGAD
can be explored by a receiver operating characteristic
(ROC) analysis [26]. The analysis produces a ROC curve
in which the sensitivity is plotted against the specificity
for each value of the test. The probability that a test will
correctly classify the individuals is estimated by the area
under the curve (AUC). The AUC is indexed from 0 to 1,
values greater than 0.50 are interpreted as a probability
greaterthanchance.Cut-offscoresforoptimalsensitivity
(the score that optimized sensitivity without reducing
specificity to less than chance), optimal specificity (the
scorethatoptimizedspecificitywithoutreducingsensitiv-
ity to less than chance), and optimal sensitivity and spe-
cificity (the score that produced the best balance of
sensitivity and specificity) were calculated for values of
the PSWQ total score.
To investigate whether patients with GAD differ from pa-
tientswithdepressivedisordersorotheranxietydisorders
in their amount of pathological worry measured by the
PSWQ, a sub-sample of N=118 patients with anxiety dis-
orders (F40/41) and depressive disorders (F32, F33,
F34)wasexamined.Patientswithotherprimary/comorbid
disorders than the mentioned disorders were excluded.
The sample of N=118 patients was divided into five
subgroups (see Table 2). Group 1 “Pure GAD“ (n=11)
consists of patients suffering from GAD without any co-
morbidity. Group 2 “GAD & Depression“ (n=12) consists
of patients with GAD and depressive disorders, but
withoutanyotheranxietydisorder.Group3“Depression“
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(n=50) consists of patients with a primary diagnosis of
depression without a comorbid GAD or another anxiety
disorder. The fourth group “Anxiety“(n=13) consists of
patients with anxiety disorders without comorbid GAD or
depression. Group 5 “Anxiety & Depression” (n=32) con-
sists of patients with anxiety disorders (except for GAD)
and comorbid depressive disorder.
Differencesregardingpathologicalworryanddepression
measured by the PSWQ and the BDI across the five
diagnostic subgroups were examined by conducting one-
way ANOVAs. Bonferroni adjusted alpha (0.05/2) was
α=0.025. The influence of depression on pathological
worry was controlled by conducting an ANCOVA with BDI
score as a covariate. All calculations were made using
SPSS 12.0.
Results
The total sample of N=237 patients had a PSWQ score
of 52.5 (10.41). By dividing the sample into patients with
GAD as primary or comorbid diagnosis versus patients
with all other diagnoses, GAD patients (n=32) reached a
PSWQ score of 57.81 (8.42), while Non-GAD patients
(n=205) had a PSWQ score of 51.67 (10.47). This differ-
enceissignificant(one-tailedt-test,t(47)=3.701,p<.001)
with a medium effect-size of d=.65 according to Cohen
[25].
The ROC analysis (see Figure 1) showed an area under
the curve of AUC=.67 (p=0.02). According to Fresco et
al.[13],threePSWQcut-offscoreswerecalculated.When
sensitivity is optimized, a cut-off score of 51 with a
sensitivity of .77 and a specificity of .51 resulted. If spe-
cificity should be more important, a cut-off score of 56
with a sensitivity of .52 and a specificity of .68 resulted.
By simultaneously optimizing both sensitivity and spe-
cificity a cut-off score of 54 with a sensitivity of .58 and
aspecificityof.60wasfound.Toensuretheidentification
of positive cases, we considered the sensitivity of a
screening instrument most important. When sensitivity
is optimized, a cut-off score of 51 resulted and 77.4% of
the GAD patients were correctly classified (25 patients),
whereas 22.6% GAD patients were not identified (7 pa-
tients). In the group of Non-GAD patients only 51% of the
4/7 GMS Psycho-Social-Medicine 2009, Vol. 6, ISSN 1860-5214
Salzer et al.: Screening for Generalized Anxiety Disorder in inpatient ...Figure 1: ROC curve for the PSWQ total score of patients with GAD and Non-GAD (N=237)
patients(104patients)werecorrectlyclassified,whereas
49% (101 patients) were falsely classified as GAD pa-
tients. Taken together, only 54.4% of the patients were
correctly classified.
To compare GAD patients with patients suffering from
depressive disorders and/or other anxiety disorders re-
garding pathological worry, measured by the PSWQ, a
sub-sample of N=118 patients was examined. The total
sub-sample reached a PSWQ score of 54.62 (10.14) and
a BDI score of 22.88 (9.85). Correlation between PSWQ
and BDI was r=.51 (p<.01). Table 2 shows the mean
scores and standard deviations in the PSWQ and BDI in
the diagnostic subgroups.
One-wayANOVAsshowedsignificantdifferencesbetween
the subgroups in the PSWQ (F(4)=5.46, p<.001;
Bonferroni post-hoc comparisons with p<.05: 2>4, 3>4,
4>5) as well as in the BDI (F(4)=17.18, p<.0001;
Bonferroni post-hoc comparisons with p<.05: 1<2, 1<3,
1<5, 2>4, 4<3, 4<5). After conducting an ANCOVA to
controlfortheinfluenceofdepression(BDI),nosignificant
differences between the diagnostic subgroups could be
found in the PSWQ (F(4)=1.53, p=.20).
Discussion
In this study, GAD patients reported a significant higher
levelofpathologicalworrywithamediumeffectmeasured
by the PSWQ than do all other patients of the inpatient
sample. Nevertheless, compared to earlier results, the
GAD patients in this sample scored lower than those of
other clinical samples [12], [13], although they scored
higher than the normal population [21].
The ROC analysis demonstrated a weak result with only
54.4% of the patients correctly classified. This result
suggests rather insufficient screening abilities of the
PSWQforGADinthisunselectedsampleofpsychotherapy
inpatients.Ifitispresumedthataspecificityofpathologic-
alworriesforGADexists[9],thanitseemsasifthePSWQ
is not able to indicate this specificity. So the instrument
could be able to detect worry valid, but not specific
enough to discriminate between different disorders.
Anotherpossibilityisthatpathologicalworryingisnotthat
specific for GAD [17], [18]. If pathological worrying can
also be found in depressive disorders as well as in other
anxietydisorders,thefactofnearlythehalfofallpatients
(49% of the sample) falsely classified as GAD patients in
this study becomes comprehensible. This consideration
is supported by the analyses of the five diagnostic sub-
groups. The subgroups exhibited significant differences
regardingtheirlevelofpathologicalworryanddepression.
After controlling for the influence of depression, differ-
ences referring to pathological worry no longer existed.
Thisresultshowsthatpathologicalworryisnotasspecific
forGADasitiscommonlypostulated.Insteadofthat,our
findings stress the meaning of comorbid depression in
GAD and further show a relevant impact of depressive
symptoms on the process of worrying. Thus, it could be
useful to recognize GAD as a “matrix of anxious-somatic-
depressivesymptoms”[27]ratherthantooveremphasize
the specificity of pathological worry in GAD.
Overall, it is important to note that the PSWQ was de-
veloped as a measure for severity of pathological worry
and it was never intended to be used as a screening in-
strumentforGAD.BecauseofthefactthatGADisawider
conceptthanpathologicalworry,aninabilityofthePSWQ
to screen effectively for GAD should not automatically be
regarded as a flaw of this instrument.
Although in general such a poor screening result could
also be caused by weaknesses regarding the reliability
and validity of the given diagnoses, the use of structured
clinicalinterviewsconductedbyexperiencedpsychother-
5/7 GMS Psycho-Social-Medicine 2009, Vol. 6, ISSN 1860-5214
Salzer et al.: Screening for Generalized Anxiety Disorder in inpatient ...apists under regular supervision speak rather against
such an explanation for the presented results.
OneshortcomingofourstudyisthesmallnumberofGAD
patients in our clinical sample, which also suggests that
GADisnotveryfrequentininpatientsettings.Inaddition,
comparedtootherGADsamples,theGADpatientsofour
sample scored rather moderate on the PSWQ. Therefore,
they could also be rather less prototypical for GAD. An-
otherimportantlimitationistherestrictedgeneralizability,
which is associated with the rather unique feature of the
German health care system, where patients suffering
fromAxisIdisorderscanreceivein-patientpsychotherapy
treatment.Thus,asimplegeneralisationtootherinpatient
settings outside of Germany would not be adequate.
Taken together, our results suggest that the PSWQ is
rather inapplicable as a screening instrument for GAD in
the context of German inpatient settings. Instead of that,
insuchacontextthePSWQcouldbeusedtodiscriminate
high versus low worriers independent of the respective
classificatorydiagnoses.Therefore,theinstrumentcould
provide the building of e.g., symptom-orientated therapy
groups as they are established in behavioural-medicine
inpatient settings. Such an approach also makes allow-
anceforthehighratesofcomorbiditiesinAxisIdisorders.
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